Sugi Predict

Sugi Predict / Compounds / SCHEMBL4976795

SCHEMBL4976795

SCHEMBL4976795

O=C(CC(=O)C(F)(F)F)CC(F)(F)F

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PLOD2 O00469 3/20 0.38
▸ PLOD3 O60568 2/20 0.36
▸ PLOD1 Q02809 2/20 0.36
▸ FAAH O00519 8/20 0.34
▸ CES1 P23141 6/20 0.33
▸ CES2 O00748 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ CA2 P00918 1/20 0.32
▸ PLA2G4A P47712 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9720470 0.83 PLOD2 (0.43) PLOD2PLOD3PLOD1FAAHCES1
SCHEMBL19320232 0.83 PLA2G4A (0.35) MEN1KMT2AALDH1A1POLBSMN1; SMN2
SCHEMBL11983874 0.80 FAAH (0.37) PLOD2PLOD3PLOD1FAAHCES1
SCHEMBL11983876 0.80 PLA2G4A (0.33) PLA2G4A
SCHEMBL2892041 0.77 FAAH (0.40) PLOD2FAAHCES1CES2MEN1
SCHEMBL9122734 0.77 KDM4E (0.41) PLOD2PLOD3PLOD1FAAHCES1
SCHEMBL23009478 0.77 PLA2G4A (0.32) PLA2G4A
SCHEMBL1058273 0.76 PLA2G4A (0.38) PLA2G4A
SCHEMBL183178 0.76 PLOD2 (0.46) PLOD2PLOD3PLOD1FAAHCES1
SCHEMBL5211347 0.76 LDHA (0.42) ALDH1A1PLA2G4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112921320-A Wet etching method and etching solution 中央硝子株式会社 2021-06-08 — — CN claimed
CN-107533971-B Wet etching method and etching solution 中央硝子株式会社 2021-01-26 — — CN claimed
US-20180138053-A1 Wet Etching Method and Etching Solution CENTRAL GLASS COMPANY, LIMITED (JP) 2018-05-17 — — US claimed
EP-3960648-B1 B-DIKETONE STORAGE CONTAINER AND PACKAGING METHOD CENTRAL GLASS CO LTD (JP) 2024-08-14 — — EP disclosed
US-12006096-B2 Beta-diketone storage container and packaging method CENTRAL GLASS COMPANY, LIMITED 2024-06-11 — — US disclosed
US-20240055273-A1 Wet Etching Solution and Wet Etching Method CENTRAL GLASS COMPANY, LIMITED (JP) 2024-02-15 — — US disclosed
US-20230374669-A1 Wet Etching Method CENTRAL GLASS COMPANY, LIMITED (JP) 2023-11-23 — — US disclosed
US-20220227531-A1 Beta-Diketone Storage Container and Packaging Method CENTRAL GLASS COMPANY, LIMITED (JP) 2022-07-21 — — US disclosed
WO-2022149565-A1 WET ETCHING SOLUTION AND WET ETCHING METHOD セントラル硝子株式会社 2022-07-14 — — WO disclosed
WO-2022080288-A1 WET ETCHING METHOD セントラル硝子株式会社 2022-04-21 — — WO disclosed
EP-3960648-A1 B-DIKETONE STORAGE CONTAINER AND PACKAGING METHOD Central Glass Company, Limited (JP) 2022-03-02 — — EP disclosed
US-7163945-B2 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase PHARMIX CORP. (US) 2007-01-16 — — US disclosed
US-20070004758-A1 COMPOSITIONS AND TREATMENTS FOR INHIBITING KINASE AND/OR HMG-COA REDUCTASE NUMERATE, INC. 2007-01-04 — — US disclosed
US-20060084695-A1 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase NUMERATE, INC. 2006-04-20 — — US disclosed
WO-2006028524-A2 COMPOSITIONS AND TREATMENTS FOR INHIBITING KINASE AND/OR HMG-COA REDUCTASE PHARMIX CORPORATION (US) 2006-03-16 — — WO disclosed
US-20050288306-A1 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase NUMERATE, INC. 2005-12-29 — — US disclosed
US-20050282883-A1 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase NUMERATE, INC. 2005-12-22 — — US disclosed
US-20050277653-A1 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase NUMERATE, INC. 2005-12-15 — — US disclosed
US-20050272770-A1 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase NUMERATE, INC. 2005-12-08 — — US disclosed
US-20050261354-A1 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase NUMERATE, INC. 2005-11-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288306-A1 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase HMGCR, HMGB3, HMGB2 PLOD2 3136/4885PLOD3 2328/4885PLOD1 2969/4885
US-20050282883-A1 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase HMGCR, HMGB3, HMGB2 PLOD2 3184/4885PLOD3 2321/4885PLOD1 3005/4885
US-20060084695-A1 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase HMGCR, HMGB3, HMGB2 PLOD2 3136/4885PLOD3 2328/4885PLOD1 2969/4885
US-20050277653-A1 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase HMGCR, HMGB3, HMGB2 PLOD2 3136/4885PLOD3 2328/4885PLOD1 2969/4885
US-20070004758-A1 COMPOSITIONS AND TREATMENTS FOR INHIBITING KINASE AND/OR HMG-COA REDUCTASE HMGCR, HMGB3, HMGB2 PLOD2 3136/4885PLOD3 2328/4885PLOD1 2969/4885
US-20050261354-A1 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase HMGCR, HMGB3, HMGB2 PLOD2 3136/4885PLOD3 2328/4885PLOD1 2969/4885
US-20050272770-A1 Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase HMGCR, HMGB3, HMGB2 PLOD2 3136/4885PLOD3 2328/4885PLOD1 2969/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.